Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-020145
Filing Date
2019-03-18
Accepted
2019-03-18 21:21:08
Documents
1
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8253
  Complete submission text file 0001209191-19-020145.txt   9590
Mailing Address 101 NORTH CHERRY STREET SUITE 501 WINSTON-SALEM NC 27101
Business Address
CASTANEDA MARK (Reporting) CIK: 0001247157 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38594 | Film No.: 19690051

Mailing Address 1920 EASTLAKE AVENUE E. SEATTLE WA 98102
Business Address 1920 EASTLAKE AVENUE E. SEATTLE WA 98102 2064329325
Tilray, Inc. (Issuer) CIK: 0001731348 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products